Clinical Trials
2
Active:1
Completed:0
Trial Phases
2 Phases
Phase 1:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 1
1 (50.0%)A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD
Not Applicable
Not yet recruiting
- Conditions
- Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)
- Interventions
- Other: Sham procedure control
- First Posted Date
- 2025-09-08
- Last Posted Date
- 2025-09-08
- Lead Sponsor
- Bionic Sight LLC
- Target Recruit Count
- 40
- Registration Number
- NCT07158775
BS01 in Patients With Retinitis Pigmentosa
- First Posted Date
- 2020-02-20
- Last Posted Date
- 2025-08-27
- Lead Sponsor
- Bionic Sight LLC
- Target Recruit Count
- 20
- Registration Number
- NCT04278131
- Locations
- πΊπΈ
New Jersey Retina, Teaneck, New Jersey, United States
News
No news found